|
The aim of the Clinical Standards Board for medicines (GMMMG) is to: support the commissioning of patient orientated outcomes and packages of care, by viewing medicines and treatments as an investment in improving health and wellbeing rather than a cost. The Clinical Standards Board (CSB) will:
- Make recommendations to ensure that the most appropriate choice of clinically and cost effective medicines are used to meet the needs of the GM population.
- Support and engage with the public, patients, commissioners and clinicians to reduce the inappropriate use of medicines.
- Set high quality standards; monitor and report against standards with the aim of to reducing unwarranted clinical variation.
- Support GM organisations to identify unwarranted variation locally. The Clinical Standards Board will promote quality improvement with better utilisation of data and analytics and sharing of best practice between organisations.
- Oversee a Greater Manchester Joint formulary, manage the introduction of new drugs, define safe prescribing practices and work with other stakeholders to facilitate the development and implementation of evidence based treatment pathways.
The work plan of the CSB is facilitated and supported by the Regional Drug & Therapeutics Centre in Newcastle and the Greater Manchester Shared Service.
|
